GSK stock price prediction: Consolidation near GBX1,944 resistance

Traders Union
All News
Stocks
GSK gains 0.18% today to GBX1,919

Highlights

Shares of GSK trade above short- and medium-term moving averages but remain below the longer-term average, indicating mixed momentum.
Technical indicators show a strong short-term bullish bias with overbought conditions and low intraday volatility.
GSK stock is expected to trade between GBX1,862 to GBX1,976 in the coming days, with high probability for further gains unless support breaks.

Overbought signals emerge as bullish momentum faces resistance

On the H1 chart, GSK is positioned above the MA-20 at GBX1,888 and the MA-50 at GBX1,857, while remaining capped by the MA-200 on the daily timeframe at GBX1,944. The Ichimoku Kijun sits at GBX1,881, offering immediate daily support. Momentum indicators confirm a firmly bullish short-term bias: MACD and ADX signal Buy, while RSI, Stoch RSI, and CCI are registering overbought readings. Bull/Bear Power underscores strong buyer dominance in intraday trading, and the Awesome Oscillator supports this bullish sentiment. Despite these signals, price action is near today’s low with muted intraday volatility, suggesting possible hesitation after the current move.

Sideways consolidation expected as rangebound volatility persists

In the coming sessions, GSK is likely to fluctuate within a volatility band of GBX1,862 to GBX1,976. The up-move probability remains very high, with a notably low likelihood of a sustained move below support. The baseline case calls for sideways consolidation within this projected range. A break above resistance could open the path to further gains, while a slip below support would shift focus to the lower end of the range.

Viktoras Karapetjanc, analyst at Traders Union, sees GSK holding firm above key supports with bullish momentum prevailing. He notes that strong intraday buyer power signals confidence, though immediate price action remains subdued. The analyst believes the absence of major news means sentiment will hinge on technical factors in the short run. He expects GSK to consolidate within its projected volatility band. "Momentum and structure support further upside as long as support holds — I remain constructive on GSK here."

In a recent review, analysts highlighted that GSK's trend remained broadly bearish with downside risks, despite intermittent short-term momentum. The latest technical signals now point to a pronounced short-term bullish bias, but with price action near session lows, traders should watch for potential consolidation or renewed volatility within the projected trading band.

Source of Data: GSK Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.